Skip to content
Battling Chronic Pain episode artwork

May 12, 2017 5 min

Battling Chronic Pain

from Arizona Science

Research into new therapies for chronic pain.

Episode details come from the podcast's RSS feed.

Embed this episode

Chronic pain affects more than 100 million adults in the U.S. alone. When our peripheral nerves are injured by trauma, disease, or toxins, they can become over-excited, resulting in debilitating chronic "neuropathic" pain. That pain may then lead to substance abuse, depression and even suicide. Todd Vanderah's research team at UA is addressing the fact that neuropathic pain does not respond well to existing therapies, which include standard analgesics such as aspirin and acetaminophen, and opioid drugs such as morphine and oxycodone which have the complication of potential addiction and abuse. In studying the mechanisms underlying the neuropathic pain of metastatic-induced bone cancer, they have discovered that a particular non-mind altering (non-rewarding) CB2 cannabinoid significantly relieves the pain. An additional exciting finding is that the CB2 receptors are found to actually reduce the rewarding effects of opioid drugs, thus also opening the door to developing new treatments to reduce the problem of addiction to opioids. In this episode: Todd W. Vanderah, PhD, Professor and Head, Department of Pharmacology; Leslie Tolbert, PhD, Regents' Professor in Neuroscience

Ready to play

Battling Chronic Pain

0:00 5:14

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Arizona Science?

This episode is 5 minutes long.

When was this Arizona Science episode published?

This episode was published on May 12, 2017.

Can I download this Arizona Science episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.